Cure My Disease

Don't miss your cure!

 Log in / Sign up

Organ transplant may offer new hope for rare abdominal cancer patients

NCT ID NCT06084780

Not yet recruiting Disease control Sponsor: Case Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an intestinal or multivisceral transplant can help people with a rare abdominal cancer called pseudomyxoma peritonei (PMP) that cannot be removed by surgery. Twenty participants will receive the transplant and be followed for 12 months to see if they survive and how safe the procedure is. The goal is to control the disease, not to cure it, as lifelong anti-rejection medication is needed after transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSEUDOMYXOMA PERITONEI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pseudomyxoma peritonei retroperitoneal cancer secondary malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSEUDOMYXOMA PERITONEI SECONDARY MALIGNANT NEOPLASM OF PERITONEUM SECONDARY MALIGNANT NEOPLASM OF RETROPERITONEUM

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), Case Comprehensive Cancer Center

    Cleveland, Ohio, 44195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••